MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma. 2022

Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
Department of Surgery, Level 7, Bridge E, Steve Biko Academic Hospital, Faculty of Health Sciences, University of Pretoria, Private Bag X323, Arcadia 0007, South Africa.

MicroRNAs (miRNA) are small non-coding RNAs that are 20-23 nucleotides in length, functioning as regulators of oncogenes or tumor suppressor genes. They are molecular modulators that regulate gene expression by suppressing gene translation through gene silencing/degradation, or by promoting translation of messenger RNA (mRNA) into proteins. Circulating miRNAs have attracted attention as possible prognostic markers of cancer, which could aid in the early detection of the disease. Epithelial to mesenchymal transition (EMT) has been implicated in tumorigenic processes, primarily by promoting tumor invasiveness and metastatic activity; this is a process that could be manipulated to halt or prevent brain metastasis. Studies show that miRNAs influence the function of EMT in glioblastomas. Thus, miRNA-related EMT can be exploited as a potential therapeutic target in glioblastomas. This review points out the interrelation between miRNA and EMT signatures, and how they can be used as reliable molecular signatures for diagnostic purposes or targeted therapy in glioblastomas.

UI MeSH Term Description Entries
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D058750 Epithelial-Mesenchymal Transition Phenotypic changes of EPITHELIAL CELLS to MESENCHYME type, which increase cell mobility critical in many developmental processes such as NEURAL TUBE development. NEOPLASM METASTASIS and DISEASE PROGRESSION may also induce this transition. Epithelial-Mesenchymal Transformation,Epithelial Mesenchymal Transformation,Epithelial Mesenchymal Transition,Transformation, Epithelial-Mesenchymal,Transition, Epithelial-Mesenchymal
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
July 2023, International journal of molecular sciences,
Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
May 2022, International journal of molecular sciences,
Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
August 2020, BMC research notes,
Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
October 2010, Annals of oncology : official journal of the European Society for Medical Oncology,
Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
August 2011, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
September 2013, Gut,
Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
March 2016, Oncology letters,
Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
January 2021, Bioscience reports,
Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
January 2018, Advances in experimental medicine and biology,
Botle Precious Setlai, and Rodney Hull, and Rui Manuel Reis, and Cyril Agbor, and Melvin Anyasi Ambele, and Thanyani Victor Mulaudzi, and Zodwa Dlamini
March 2024, Heliyon,
Copied contents to your clipboard!